Alethea Capital Management’s Amgen AMGN Stock Holding History

Alethea Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-500	Closed	-$2K	–	79
2020 Q4	$2K	Buy	+500	New	+$115K	﹤0.01%	73

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Alethea Capital Management's AMGN Position: Q1 2025 in Review

Alethea Capital Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 1,330 shares — an estimated $347K sold.

Alethea Capital Management first reported a position in AMGN in Q2 2017 and held it in 26 quarters. The position peaked at $1.35M in Q4 2019. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

Alethea Capital Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
Alethea Capital Management sold 1,330 Amgen shares in Q1 2025, an estimated $347K.
Alethea Capital Management first reported a position in Amgen in Q2 2017 and held it in 26 quarters.
Alethea Capital Management's Amgen position peaked at $1.35M in Q4 2019.
2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Alethea Capital Management's 13F filing for Q1 2025, filed 14 May 2025.